Lynne D. Richardson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lynne D. Richardson has a total of 274 co-authors. Here are the top co-authors by number of shared publications:
- Carol R. Horowitz
Department of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New York USA
6 shared publications - Kimberly Souffront
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Center for Nursing Research and Innovation, Mount Sinai Health System, 1 Gustave L. Levy Place New York, NY 10029, USA
6 shared publications - Marcee Wilder
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
6 shared publications - Ethan E. Abbott
Icahn School of Medicine at Mount Sinai
5 shared publications - Girish N. Nadkarni
The Windreich Department of Artificial Intelligence and Human Health, Mount Sinai Medical Center, NY, USA
5 shared publications - Lauren Gordon
Icahn School of Medicine at Mount Sinai, New York, New York, USA, mountsinai.org
5 shared publications
Latest Publications
- Open Access
OHCA-EXTRACT: Evaluating the Accuracy of a Large Language Model Pipeline for Out-of-Hospital Cardiac Arrest Case Identification and Utstein Variable Extraction
Background: Manual identification and abstraction of out-of-hospital cardiac arrest (OHCA) cases and Utstein template variables from electronic health records is resource-intensive and limits scalable measurement for observational research and registry participation. We evaluated a large language model (LLM)–assisted pipeline to identify true OHCA encounters within an ICD-coded emergency department (ED) cohort and to also extract a limited set of Utstein variables from unstructured documentation, with iterative pipeline refinement and final performance evaluation conducted on the same validation cohort. Methods: We conducted a study of ICD-flagged OHCA encounters within a large urban academic health system (2015–2024). A two-module pipeline was developed that included an identification module and a variable-extraction module. The pipeline was evaluated against independent manual chart abstraction on a validation sample (n = 176) with physician adjudication. The identification module performed binary OHCA classification along with etiology classification. The variable-extraction module extracted five Utstein variables: witnessed status, EMS defibrillation, first recorded rhythm, arrest location, and bystander response. We calculated sensitivity, specificity, PPV, NPV, and F1 scores (Clopper–Pearson 95% CIs) using the manual chart abstraction as the reference gold standard. Results: Of 176 processed encounters, 152 had complete gold-standard classification and were included in identification analyses (OHCA prevalence 81.6%; n = 124 true OHCA, n = 28 non-OHCA). The identification module achieved an accuracy of 0.91 (95% CI 0.85–0.95), sensitivity 0.94 (0.89–0.98), specificity 0.75 (0.55–0.89), PPV 0.94 (0.89–0.98), NPV 0.75 (0.55–0.89), and F1 0.94, compared with accuracy 0.82 for a prevalence-only baseline. Variable-level accuracy ranged from 0.63 to 0.75 (Kappa range 0.31–0.51) across the five extracted Utstein variables, with bystander response showing the lowest agreement (accuracy 0.63, Kappa = 0.31). Conclusions: Within-sample performance estimates indicate that this LLM pipeline can identify true OHCA encounters within an ICD-flagged ED cohort with accuracy and PPV above an administrative-coding baseline. Variable-level extraction accuracy ranged from fair to moderate across the five evaluated Utstein variables, indicating that further methodological development is required before automated extraction is feasible. With external validation and integration with targeted human verification, this approach may support human-augmented workflows using LLMs, however independent external validation is required before our findings can be generalized.
Open AccessOHCA-EXTRACT: Evaluating the Accuracy of a Large Language Model Pipeline for Out-of-Hospital Cardiac Arrest Case Identification and Utstein Variable Extraction
Background: Manual identification and abstraction of out-of-hospital cardiac arrest (OHCA) cases and Utstein template variables from electronic health records is resource-intensive and limits scalable measurement for observational research and registry participation. We evaluated a large language model (LLM)–assisted pipeline to identify true OHCA encounters within an ICD-coded emergency department (ED) cohort and to also extract a limited set of Utstein variables from unstructured documentation, with iterative pipeline refinement and final performance evaluation conducted on the same validation cohort. Methods: We conducted a study of ICD-flagged OHCA encounters within a large urban academic health system (2015–2024). A two-module pipeline was developed that included an identification module and a variable-extraction module. The pipeline was evaluated against independent manual chart abstraction on a validation sample (n = 176) with physician adjudication. The identification module performed binary OHCA classification along with etiology classification. The variable-extraction module extracted five Utstein variables: witnessed status, EMS defibrillation, first recorded rhythm, arrest location, and bystander response. We calculated sensitivity, specificity, PPV, NPV, and F1 scores (Clopper–Pearson 95% CIs) using the manual chart abstraction as the reference gold standard. Results: Of 176 processed encounters, 152 had complete gold-standard classification and were included in identification analyses (OHCA prevalence 81.6%; n = 124 true OHCA, n = 28 non-OHCA). The identification module achieved an accuracy of 0.91 (95% CI 0.85–0.95), sensitivity 0.94 (0.89–0.98), specificity 0.75 (0.55–0.89), PPV 0.94 (0.89–0.98), NPV 0.75 (0.55–0.89), and F1 0.94, compared with accuracy 0.82 for a prevalence-only baseline. Variable-level accuracy ranged from 0.63 to 0.75 (Kappa range 0.31–0.51) across the five extracted Utstein variables, with bystander response showing the lowest agreement (accuracy 0.63, Kappa = 0.31). Conclusions: Within-sample performance estimates indicate that this LLM pipeline can identify true OHCA encounters within an ICD-flagged ED cohort with accuracy and PPV above an administrative-coding baseline. Variable-level extraction accuracy ranged from fair to moderate across the five evaluated Utstein variables, indicating that further methodological development is required before automated extraction is feasible. With external validation and integration with targeted human verification, this approach may support human-augmented workflows using LLMs, however independent external validation is required before our findings can be generalized.
- Open Access
- 19 January 2026
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 9 (1)
Social Determinants of Health and Uncontrolled Hypertension in Emergency Department Patients: A Multicenter Analysis
Objective: The role of social determinants of health (SDOH) among adult emergency department (ED) patients with hypertension remains largely unexplored. This study aims to address this critical knowledge gap. Methods: Electronic Health Record data from patients visiting six urban EDs between September 1, 2019, and October 21, 2022 with hypertension [Stage 1 hypertension (two blood pressure readings ≥ 130/80 mmHg)] or Stage 2 hypertension (≥140/90 mmHg)] were obtained along with their demographic and social characteristics such as employment, age, sex, insurance status and comorbidities. Bivariate analysis and multivariate regression modeled the odds of hypertension with demographic and social data, reported as odds ratios (OR) with 95% confidence intervals (CI). Results: Among 822,843 encounters, 22.8% (n = 187,664) involved patients with Stage 1 hypertension. These patients were middle-aged (mean age 60 years) and were more likely to have a prior diagnosis of hypertension (OR 3.02, 95% CI 2.96–3.09), be male (OR 1.14, 95% CI 1.12–1.14), African American (OR 1.40, 95% CI 1.37–1.42), and current smokers (OR 1.05, 95% CI 1.03–1.06), and less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.92). Stage 2 hypertension occurred in 13.0% of encounters (n = 109,231). These patients had a similar mean age (63 years) and showed comparable associations, including higher odds of being African American (OR 1.61, 95% CI 1.58–1.64), unemployed (OR 0.50, 95% CI 0.47–0.52), having a prior hypertension diagnosis (OR 3.37, 95% CI 3.30–3.45), and smoking (OR 1.09, 95% CI 1.06–1.11). They were also less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.93) or to present during the COVID period (OR 0.92, 95% CI 0.89–0.95). Conclusions: In this large, multicenter ED-based cohort, elevated blood pressure was consistently associated with key social and demographic factors, including race/ethnicity, insurance status, employment, and smoking. These findings underscore the importance of considering social context when evaluating hypertension in emergency department settings.
- 19 January 2026
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 9 (1)
Open AccessSocial Determinants of Health and Uncontrolled Hypertension in Emergency Department Patients: A Multicenter Analysis
Objective: The role of social determinants of health (SDOH) among adult emergency department (ED) patients with hypertension remains largely unexplored. This study aims to address this critical knowledge gap. Methods: Electronic Health Record data from patients visiting six urban EDs between September 1, 2019, and October 21, 2022 with hypertension [Stage 1 hypertension (two blood pressure readings ≥ 130/80 mmHg)] or Stage 2 hypertension (≥140/90 mmHg)] were obtained along with their demographic and social characteristics such as employment, age, sex, insurance status and comorbidities. Bivariate analysis and multivariate regression modeled the odds of hypertension with demographic and social data, reported as odds ratios (OR) with 95% confidence intervals (CI). Results: Among 822,843 encounters, 22.8% (n = 187,664) involved patients with Stage 1 hypertension. These patients were middle-aged (mean age 60 years) and were more likely to have a prior diagnosis of hypertension (OR 3.02, 95% CI 2.96–3.09), be male (OR 1.14, 95% CI 1.12–1.14), African American (OR 1.40, 95% CI 1.37–1.42), and current smokers (OR 1.05, 95% CI 1.03–1.06), and less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.92). Stage 2 hypertension occurred in 13.0% of encounters (n = 109,231). These patients had a similar mean age (63 years) and showed comparable associations, including higher odds of being African American (OR 1.61, 95% CI 1.58–1.64), unemployed (OR 0.50, 95% CI 0.47–0.52), having a prior hypertension diagnosis (OR 3.37, 95% CI 3.30–3.45), and smoking (OR 1.09, 95% CI 1.06–1.11). They were also less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.93) or to present during the COVID period (OR 0.92, 95% CI 0.89–0.95). Conclusions: In this large, multicenter ED-based cohort, elevated blood pressure was consistently associated with key social and demographic factors, including race/ethnicity, insurance status, employment, and smoking. These findings underscore the importance of considering social context when evaluating hypertension in emergency department settings.
- Open Access
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Preliminary Associations Between Diagnosis of Asthma/COPD and Neighborhood Vulnerability Among Adults with Chronic Illness from the Predicting Risk and Investigating Outcomes Using Patient-Reported and Community Level Data (PRIORITY) Cohort
Background: Asthma and COPD are common chronic conditions that disproportionately affect underserved communities. Despite improvements in air quality and medical interventions, this gap remains. While individual-level risk factors are well-understood, less is known about how neighborhood-level social factors impact respiratory disease burden. Methods: We analyzed preliminary data from PRIORITY, a prospective cohort study of randomly selected adult emergency department patients with chronic illnesses and their social determinants of health. Each patient's residential address was linked to their neighborhood's Social Vulnerability Index (SVI). SVI is a composite score ranging from 0 to 1, reflecting area-level structural disadvantage across four domains: socioeconomic status, household characteristics, racial/ethnic minority composition, and housing/transportation. The primary outcome was a diagnosis of asthma and/or COPD at enrollment. We conducted bivariate logistic regression to assess associations between asthma/COPD and both overall SVI and its four domains, reporting odds ratios (OR) and 95% confidence intervals (CI). Results: We analyzed 338 participants with a mean age 53.5 years, 62.7% female, and common comorbidities included hypertension, diabetes. Higher overall SVI was associated with increased odds of asthma/COPD (OR: 3.95, 95% CI: 1.33-12.1). Significant associations were also found for neighborhood-level socioeconomic status (OR: 3.32, 95% CI: 1.32-8.57) and racial/ethnic minority composition (OR: 7.32, 95% CI: 1.81-31.6). Conclusion: These findings highlight structural inequities in respiratory disease burden and emphasize the need for public health interventions. Future research should integrate individual-level risk factors and physical environment factors (air pollution, land use, etc.) with neighborhood-level vulnerability measures to better understand how they interact to shape respiratory outcomes in disadvantaged communities.
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Open AccessPreliminary Associations Between Diagnosis of Asthma/COPD and Neighborhood Vulnerability Among Adults with Chronic Illness from the Predicting Risk and Investigating Outcomes Using Patient-Reported and Community Level Data (PRIORITY) Cohort
Background: Asthma and COPD are common chronic conditions that disproportionately affect underserved communities. Despite improvements in air quality and medical interventions, this gap remains. While individual-level risk factors are well-understood, less is known about how neighborhood-level social factors impact respiratory disease burden. Methods: We analyzed preliminary data from PRIORITY, a prospective cohort study of randomly selected adult emergency department patients with chronic illnesses and their social determinants of health. Each patient's residential address was linked to their neighborhood's Social Vulnerability Index (SVI). SVI is a composite score ranging from 0 to 1, reflecting area-level structural disadvantage across four domains: socioeconomic status, household characteristics, racial/ethnic minority composition, and housing/transportation. The primary outcome was a diagnosis of asthma and/or COPD at enrollment. We conducted bivariate logistic regression to assess associations between asthma/COPD and both overall SVI and its four domains, reporting odds ratios (OR) and 95% confidence intervals (CI). Results: We analyzed 338 participants with a mean age 53.5 years, 62.7% female, and common comorbidities included hypertension, diabetes. Higher overall SVI was associated with increased odds of asthma/COPD (OR: 3.95, 95% CI: 1.33-12.1). Significant associations were also found for neighborhood-level socioeconomic status (OR: 3.32, 95% CI: 1.32-8.57) and racial/ethnic minority composition (OR: 7.32, 95% CI: 1.81-31.6). Conclusion: These findings highlight structural inequities in respiratory disease burden and emphasize the need for public health interventions. Future research should integrate individual-level risk factors and physical environment factors (air pollution, land use, etc.) with neighborhood-level vulnerability measures to better understand how they interact to shape respiratory outcomes in disadvantaged communities.
- Open Access
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Preliminary Associations Between Social Cohesion and Healthcare Utilization Among Adults with Chronic Illness From the Predicting Risk and Investigating Outcomes Using Patient-Reported and Community Level Data (PRIORITY) Cohort
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Open AccessPreliminary Associations Between Social Cohesion and Healthcare Utilization Among Adults with Chronic Illness From the Predicting Risk and Investigating Outcomes Using Patient-Reported and Community Level Data (PRIORITY) Cohort
- Open Access
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Evaluating the Impact of Discrimination and Isolation in Patients with Hypertension in the Predicting Risk and Investigating Outcomes Using Patient-Reported Individual and Community-Level Data (PRIORITY) Cohort
Background: Hypertension (HTN) disproportionately affects socially marginalized groups; social determinants of health (SDOH), including discrimination, are known to contribute to poor HTN outcomes. This study explored relationships among experiences of discrimination, social isolation, and other key SDOH factors. Methods: We analyzed baseline structured interview data for enrolled patients with HTN from PRIORITY, a prospective cohort study of randomly selected adult emergency department patients with chronic illnesses. We examined validated measures of social isolation, experiences of discrimination and other SDOH. Each of four SDOH factors (financial strain, housing insecurity, employment status, social isolation) was modeled in a separate logistic regression with selfreported discrimination as the outcome. Interaction effects with social isolation were also explored to assess potential effect modification. Results: Participants (n = 255) were 57% female; 38% Latine, 46% Black, 9% White, with mean age of 59 years. Those reporting housing insecurity had significantly higher odds of experiencing discrimination compared to those without such concerns (OR: 2.0; 95% CI:1.1-3.7). Similarly, those experiencing financial strain had greater odds of reporting discrimination (OR: 2.4; 95% CI: 1.5-4.1). Feelings of loneliness or social isolation were also associated with increased odds of discrimination (OR: 2.2; 95% CI: 1.1-4.6). An interaction analysis revealed that those who were both socially isolated and un/underemployed had substantially higher odds of reporting discrimination (OR: 10.3; 95% CI: 1.42-215.0) compared to those without both conditions. Conclusion: Experiences of discrimination are associated with multiple social risks in patients with HTN, and isolation may intensify these associations. These findings support the need for equity-centered care strategies to improve health outcomes.
- 4 November 2025
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 8 (2)
Open AccessEvaluating the Impact of Discrimination and Isolation in Patients with Hypertension in the Predicting Risk and Investigating Outcomes Using Patient-Reported Individual and Community-Level Data (PRIORITY) Cohort
Background: Hypertension (HTN) disproportionately affects socially marginalized groups; social determinants of health (SDOH), including discrimination, are known to contribute to poor HTN outcomes. This study explored relationships among experiences of discrimination, social isolation, and other key SDOH factors. Methods: We analyzed baseline structured interview data for enrolled patients with HTN from PRIORITY, a prospective cohort study of randomly selected adult emergency department patients with chronic illnesses. We examined validated measures of social isolation, experiences of discrimination and other SDOH. Each of four SDOH factors (financial strain, housing insecurity, employment status, social isolation) was modeled in a separate logistic regression with selfreported discrimination as the outcome. Interaction effects with social isolation were also explored to assess potential effect modification. Results: Participants (n = 255) were 57% female; 38% Latine, 46% Black, 9% White, with mean age of 59 years. Those reporting housing insecurity had significantly higher odds of experiencing discrimination compared to those without such concerns (OR: 2.0; 95% CI:1.1-3.7). Similarly, those experiencing financial strain had greater odds of reporting discrimination (OR: 2.4; 95% CI: 1.5-4.1). Feelings of loneliness or social isolation were also associated with increased odds of discrimination (OR: 2.2; 95% CI: 1.1-4.6). An interaction analysis revealed that those who were both socially isolated and un/underemployed had substantially higher odds of reporting discrimination (OR: 10.3; 95% CI: 1.42-215.0) compared to those without both conditions. Conclusion: Experiences of discrimination are associated with multiple social risks in patients with HTN, and isolation may intensify these associations. These findings support the need for equity-centered care strategies to improve health outcomes.
- Open Access
- 4 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e71757
Detecting, Characterizing, and Mitigating Implicit and Explicit Racial Biases in Health Care Datasets With Subgroup Learnability: Algorithm Development and Validation Study
Background: The growing adoption of diagnostic and prognostic algorithms in health care has led to concerns about the perpetuation of algorithmic bias against disadvantaged groups of individuals. Deep learning methods to detect and mitigate bias have revolved around modifying models, optimization strategies, and threshold calibration with varying levels of success and tradeoffs. However, there have been limited substantive efforts to address bias at the level of the data used to generate algorithms in health care datasets. Objective: The aim of this study is to create a simple metric (AEquity) that uses a learning curve approximation to distinguish and mitigate bias via guided dataset collection or relabeling. Methods: We demonstrate this metric in 2 well-known examples, chest X-rays and health care cost utilization, and detect novel biases in the National Health and Nutrition Examination Survey. Results: We demonstrated that using AEquity to guide data-centric collection for each diagnostic finding in the chest radiograph dataset decreased bias by between 29% and 96.5% when measured by differences in area under the curve. Next, we wanted to examine (1) whether AEquity worked on intersectional populations and (2) if AEquity is invariant to different types of fairness metrics, not just area under the curve. Subsequently, we examined the effect of AEquity on mitigating bias when measured by false negative rate, precision, and false discovery rate for Black patients on Medicaid. When we examined Black patients on Medicaid, at the intersection of race and socioeconomic status, we found that AEquity-based interventions reduced bias across a number of different fairness metrics including overall false negative rate by 33.3% (bias reduction absolute=1.88×10 −1 , 95% CI 1.4×10 −1 to 2.5×10 −1 ; bias reduction of 33.3%, 95% CI 26.6%‐40%; precision bias by 7.50×10 −2 , 95% CI 7.48×10 −2 to 7.51×10 −2 ; bias reduction of 94.6%, 95% CI 94.5%‐94.7%; false discovery rate by 94.5%; absolute bias reduction=3.50×10 −2 , 95% CI 3.49×10 −2 to 3.50×10 −2 ). Similarly, AEquity-guided data collection demonstrated bias reduction of up to 80% on mortality prediction with the National Health and Nutrition Examination Survey (bias reduction absolute=0.08, 95% CI 0.07-0.09). Then, we wanted to compare AEquity to state-of-the-art data-guided debiasing measures such as balanced empirical risk minimization and calibration. Consequently, we benchmarked against balanced empirical risk minimization and calibration and showed that AEquity-guided data collection outperforms both standard approaches. Moreover, we demonstrated that AEquity works on fully connected networks; convolutional neural networks such as ResNet-50; transformer architectures such as VIT-B-16, a vision transformer with 86 million parameters; and nonparametric methods such as Light Gradient-Boosting Machine. Conclusions: In short, we demonstrated that AEquity is a robust tool by applying it to different datasets, algorithms, and intersectional analyses and measuring its effectiveness with respect to a range of traditional fairness metrics.
- 4 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e71757
Open AccessDetecting, Characterizing, and Mitigating Implicit and Explicit Racial Biases in Health Care Datasets With Subgroup Learnability: Algorithm Development and Validation Study
Background: The growing adoption of diagnostic and prognostic algorithms in health care has led to concerns about the perpetuation of algorithmic bias against disadvantaged groups of individuals. Deep learning methods to detect and mitigate bias have revolved around modifying models, optimization strategies, and threshold calibration with varying levels of success and tradeoffs. However, there have been limited substantive efforts to address bias at the level of the data used to generate algorithms in health care datasets. Objective: The aim of this study is to create a simple metric (AEquity) that uses a learning curve approximation to distinguish and mitigate bias via guided dataset collection or relabeling. Methods: We demonstrate this metric in 2 well-known examples, chest X-rays and health care cost utilization, and detect novel biases in the National Health and Nutrition Examination Survey. Results: We demonstrated that using AEquity to guide data-centric collection for each diagnostic finding in the chest radiograph dataset decreased bias by between 29% and 96.5% when measured by differences in area under the curve. Next, we wanted to examine (1) whether AEquity worked on intersectional populations and (2) if AEquity is invariant to different types of fairness metrics, not just area under the curve. Subsequently, we examined the effect of AEquity on mitigating bias when measured by false negative rate, precision, and false discovery rate for Black patients on Medicaid. When we examined Black patients on Medicaid, at the intersection of race and socioeconomic status, we found that AEquity-based interventions reduced bias across a number of different fairness metrics including overall false negative rate by 33.3% (bias reduction absolute=1.88×10 −1 , 95% CI 1.4×10 −1 to 2.5×10 −1 ; bias reduction of 33.3%, 95% CI 26.6%‐40%; precision bias by 7.50×10 −2 , 95% CI 7.48×10 −2 to 7.51×10 −2 ; bias reduction of 94.6%, 95% CI 94.5%‐94.7%; false discovery rate by 94.5%; absolute bias reduction=3.50×10 −2 , 95% CI 3.49×10 −2 to 3.50×10 −2 ). Similarly, AEquity-guided data collection demonstrated bias reduction of up to 80% on mortality prediction with the National Health and Nutrition Examination Survey (bias reduction absolute=0.08, 95% CI 0.07-0.09). Then, we wanted to compare AEquity to state-of-the-art data-guided debiasing measures such as balanced empirical risk minimization and calibration. Consequently, we benchmarked against balanced empirical risk minimization and calibration and showed that AEquity-guided data collection outperforms both standard approaches. Moreover, we demonstrated that AEquity works on fully connected networks; convolutional neural networks such as ResNet-50; transformer architectures such as VIT-B-16, a vision transformer with 86 million parameters; and nonparametric methods such as Light Gradient-Boosting Machine. Conclusions: In short, we demonstrated that AEquity is a robust tool by applying it to different datasets, algorithms, and intersectional analyses and measuring its effectiveness with respect to a range of traditional fairness metrics.
- 17 June 2025
- Published by Springer Nature in Current Hypertension Reports
- Vol. 27 (1) , 1-22
A Scoping Review of Asymptomatic Hypertension: Definitions, Diagnosis, and Management in the Emergency Department
Background This scoping review examines the existing literature to reveal consensus or absence thereof regarding the definition and management strategies for asymptomatic hypertension. Methods The review used Joanna Briggs Institute guidelines. We searched the CINAHL (EBSCO), Scopus, Ovid EMBASE, and PubMed (MEDLINE) databases using keywords and index terms to identify adult patients with hypertension in an emergency or outpatient setting. After review and quality assessment, we included 35 texts. Results The definition of “asymptomatic hypertension” varied widely. There was significant variation in which society or academic guideline served as the reference and what the blood pressure cut offs were; all specified a lack of end-organ damage. End-organ damage was poorly defined– studies instead described the absence of hypertensive emergency. Of the texts which provided recommendations, all recommended a thorough history and physical examination. Only one study recommended additional testing for asymptomatic patients. Treatment recommendations relied predominantly on ACEP clinical policy, with a majority of studies advocating for gradual reduction of blood pressure as well as referral for outpatient management. Conclusion Unified guidelines on the definition and management of asymptomatic hypertension are needed to ensure effective and consistent patient care. There is no consensus for diagnostic testing in patients with a negative history and physical exam, nor whether treatment should be initiated in the emergency department. Addressing this gap would enhance clinical outcomes and streamline healthcare processes across systems. Future research should focus on establishing consensus and developing management strategies that are adaptable to both emergency and primary care environments.
- 17 June 2025
- Published by Springer Nature in Current Hypertension Reports
- Vol. 27 (1) , 1-22
A Scoping Review of Asymptomatic Hypertension: Definitions, Diagnosis, and Management in the Emergency Department
Background This scoping review examines the existing literature to reveal consensus or absence thereof regarding the definition and management strategies for asymptomatic hypertension. Methods The review used Joanna Briggs Institute guidelines. We searched the CINAHL (EBSCO), Scopus, Ovid EMBASE, and PubMed (MEDLINE) databases using keywords and index terms to identify adult patients with hypertension in an emergency or outpatient setting. After review and quality assessment, we included 35 texts. Results The definition of “asymptomatic hypertension” varied widely. There was significant variation in which society or academic guideline served as the reference and what the blood pressure cut offs were; all specified a lack of end-organ damage. End-organ damage was poorly defined– studies instead described the absence of hypertensive emergency. Of the texts which provided recommendations, all recommended a thorough history and physical examination. Only one study recommended additional testing for asymptomatic patients. Treatment recommendations relied predominantly on ACEP clinical policy, with a majority of studies advocating for gradual reduction of blood pressure as well as referral for outpatient management. Conclusion Unified guidelines on the definition and management of asymptomatic hypertension are needed to ensure effective and consistent patient care. There is no consensus for diagnostic testing in patients with a negative history and physical exam, nor whether treatment should be initiated in the emergency department. Addressing this gap would enhance clinical outcomes and streamline healthcare processes across systems. Future research should focus on establishing consensus and developing management strategies that are adaptable to both emergency and primary care environments.
- Open Access
- 29 May 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67195
Validating a Patient-Reported Outcome Measure to Improve Emergency Department Asthma Care: Protocol for an Observational Study
Background: Asthma affects 1 in every 12 persons in the United States, resulting in 1.9 million emergency department (ED) visits annually. However, the lack of patient-reported outcome measures (PROMs) validated for use in the ED limits the evaluation of interventions to improve ED asthma care. Objective: To address this knowledge gap, this study protocol will (1) develop and test the validity and reliability of the Patient Reported Outcomes for Acute Asthma Care and Treatment instrument (PROAACT), (2) test whether receiving more guideline-concordant ED care is associated with improved PROAACT responses, and (3) evaluate the association between PROAACT score and subsequent ED revisits and hospitalizations. Methods: This is a prospective cohort study of adult patients visiting the ED for acute asthma exacerbation across 3 EDs at an urban, tertiary care health system. Eligible patients are 18 years or older, have a prior diagnosis of asthma (self-reported or documented in the electronic health record), are English-speaking, and experiencing an ED visit for asthma exacerbation as determined by the treating clinician. Enrolled participants complete an initial PROM survey during their ED visit assessing their symptoms in the preceding 7 days, then complete a follow-up survey 7 days after ED discharge assessing changes in the symptoms in the subsequent 7 days. To test whether guideline-concordant care is associated with improved PROAACT scores, we will conduct a retrospective chart review of medications ordered during the ED visit, and then compare guideline adherence to changes in PROAACT scores. To test whether improved PROAACT scores are associated with fewer return ED visits and hospitalizations, we will extract all-cause ED visits and hospitalizations within 30 days from a regional health information exchange, and then compare usage to changes in PROAACT scores. We will use item response theory to develop scale responses based on summed item responses, which will allow us to test associations with clinical outcomes, including adherence to guideline-recommended care and return ED visits and hospitalizations. Results: Recruitment is ongoing and has experienced numerous challenges related to the COVID-19 pandemic. To date, we have enrolled over 250 participants and have completed over 200 follow-ups. Recruitment is expected to conclude in spring 2025. Conclusions: Our study is intended to validate the use of PROMs during ED visits for acute asthma exacerbation among adult patients. Completion of the proposed aims will result in one of the first PROMs intended for use among adult ED patients and support the feasibility of collecting PROMs in the ED setting. Trial Registration: Clinical Trials.gov NCT04349020; https://clinicaltrials.gov/study/NCT04349020 International Registered Report Identifier (IRRID): DERR1-10.2196/67195
- 29 May 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67195
Open AccessValidating a Patient-Reported Outcome Measure to Improve Emergency Department Asthma Care: Protocol for an Observational Study
Background: Asthma affects 1 in every 12 persons in the United States, resulting in 1.9 million emergency department (ED) visits annually. However, the lack of patient-reported outcome measures (PROMs) validated for use in the ED limits the evaluation of interventions to improve ED asthma care. Objective: To address this knowledge gap, this study protocol will (1) develop and test the validity and reliability of the Patient Reported Outcomes for Acute Asthma Care and Treatment instrument (PROAACT), (2) test whether receiving more guideline-concordant ED care is associated with improved PROAACT responses, and (3) evaluate the association between PROAACT score and subsequent ED revisits and hospitalizations. Methods: This is a prospective cohort study of adult patients visiting the ED for acute asthma exacerbation across 3 EDs at an urban, tertiary care health system. Eligible patients are 18 years or older, have a prior diagnosis of asthma (self-reported or documented in the electronic health record), are English-speaking, and experiencing an ED visit for asthma exacerbation as determined by the treating clinician. Enrolled participants complete an initial PROM survey during their ED visit assessing their symptoms in the preceding 7 days, then complete a follow-up survey 7 days after ED discharge assessing changes in the symptoms in the subsequent 7 days. To test whether guideline-concordant care is associated with improved PROAACT scores, we will conduct a retrospective chart review of medications ordered during the ED visit, and then compare guideline adherence to changes in PROAACT scores. To test whether improved PROAACT scores are associated with fewer return ED visits and hospitalizations, we will extract all-cause ED visits and hospitalizations within 30 days from a regional health information exchange, and then compare usage to changes in PROAACT scores. We will use item response theory to develop scale responses based on summed item responses, which will allow us to test associations with clinical outcomes, including adherence to guideline-recommended care and return ED visits and hospitalizations. Results: Recruitment is ongoing and has experienced numerous challenges related to the COVID-19 pandemic. To date, we have enrolled over 250 participants and have completed over 200 follow-ups. Recruitment is expected to conclude in spring 2025. Conclusions: Our study is intended to validate the use of PROMs during ED visits for acute asthma exacerbation among adult patients. Completion of the proposed aims will result in one of the first PROMs intended for use among adult ED patients and support the feasibility of collecting PROMs in the ED setting. Trial Registration: Clinical Trials.gov NCT04349020; https://clinicaltrials.gov/study/NCT04349020 International Registered Report Identifier (IRRID): DERR1-10.2196/67195